Growth Metrics

Palisade Bio (PALI) Receivables - Other (2016 - 2023)

Palisade Bio (PALI) reported Receivables - Other of $105625.0 for Q4 2023, down 25.22% year-over-year from $141250.0 in Q4 2022, and little changed on a QoQ basis from $105625.0 in Q3 2023.

Palisade Bio (PALI) has 7 years of Receivables - Other data on file, last reported at $105625.0 in Q4 2023.

  • Quarterly Receivables - Other fell 25.22% year-over-year to $105625.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $105625.0 (down 25.22% YoY) and the FY2023 annual result came in at $105625.0, down 25.22% from the prior year.
  • Receivables - Other was little changed at $105625.0 in Q4 2023 per PALI's latest filing, from $105625.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $229000.0 in Q1 2019 and bottomed at $105625.0 in Q2 2023.
  • The 4-year median for Receivables - Other is $229000.0 (2019), against an average of $187375.0.
  • The widest annual swing landed in 2019, when Receivables - Other surged 267.88%; it then retreated 25.22% in 2023.
  • Tracing PALI's Receivables - Other over 4 years: stood at $229000.0 in 2019, then changed by 0.0% to $229000.0 in 2020, then tumbled by 38.32% to $141250.0 in 2022, then fell by 25.22% to $105625.0 in 2023.
  • Per Business Quant, the three latest PALI Receivables - Other figures stand at $105625.0 (Q4 2023), $105625.0 (Q3 2023), and $105625.0 (Q2 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Palisade Bio 439.25 Mn 309.68 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 105,625.00
Dec 31, 2023 105,625.00
Sep 30, 2023 105,625.00
Sep 30, 2023 105,625.00
Jun 30, 2023 105,625.00
Jun 30, 2023 105,625.00
Dec 31, 2022 141,250.00
Dec 31, 2022 141,250.00
Dec 31, 2020 229,000.00
Dec 31, 2020 229,000.00
Sep 30, 2020 229,000.00
Sep 30, 2020 229,000.00
Jun 30, 2020 229,000.00
Jun 30, 2020 229,000.00
Mar 31, 2020 229,000.00
Mar 31, 2020 229,000.00
Sep 30, 2019 229,000.00
Sep 30, 2019 229,000.00
Jun 30, 2019 229,000.00
Jun 30, 2019 229,000.00
Mar 31, 2019 229,000.00
Mar 31, 2019 229,000.00
Dec 31, 2018 63,938.00
Dec 31, 2018 63,938.00
Sep 30, 2018 62,248.00
Sep 30, 2018 62,248.00
Dec 31, 2017 58,784.00
Dec 31, 2017 58,784.00
Sep 30, 2017 57,291.00
Sep 30, 2017 57,291.00
Jun 30, 2017 558,000.00
Jun 30, 2017 558,000.00
Mar 31, 2017 558,000.00
Mar 31, 2017 558,000.00
Dec 31, 2016 53,081.00
Dec 31, 2016 53,081.00
Sep 30, 2016 51,733.00
Sep 30, 2016 51,733.00